2023
One-year all-cause mortality in hospitalized patients with COVID-19 and end-stage renal disease undergoing hemodialysis.
Munoz Mendoza J, Aponte-Becerra L, Torres C, Rozas J, Francois P, Salcedo J, Barreto A, Rodriguez J, Suarez M, Fornoni A, Contreras G. One-year all-cause mortality in hospitalized patients with COVID-19 and end-stage renal disease undergoing hemodialysis. Clinical Nephrology 2023, 99: 51-57. PMID: 36519940, DOI: 10.5414/cn110823.Peer-Reviewed Original ResearchConceptsEnd-stage renal diseaseCOVID-19 infectionLong-term mortality riskHospital mortalityMortality riskRenal diseaseOdds ratioCOVID-19Higher long-term mortality riskRetrospective chart reviewAdjusted odds ratioLogistic regression modelsESRD patientsCause mortalitySecondary outcomesChart reviewPrimary outcomeHospitalized patientsHigher oddsMortality ratePatientsMortalityOne-yearInfectionSignificant differences
2019
Continuous glucose monitoring in acute stroke
Aponte-Becerra L, Quispe R, Mendez-Pino L, Novak V, Selim M, Lioutas V. Continuous glucose monitoring in acute stroke. 2019, 90-95. DOI: 10.46354/i3m.2019.iwish.016.Peer-Reviewed Original ResearchAcute strokeContinuous glucose monitoringGlycaemic variabilityAssociated with poor clinical outcomesAmplitude of glucose excursionAcute stroke settingAssociated with high mortality ratesPoor clinical outcomesStroke patientsGlucose monitoringAcute brain ischemiaStroke settingPilot studyHigher mortality rateClinical outcomesPoor prognosisMortality rateCoefficient of variationHypoglycaemic episodesGlucose excursionsBrain ischemiaMonitoring regimenStrokeCompare continuous glucose monitoring